KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
14,110
-110 (-0.77%)
Last updated: May 12, 2025
KOREA PHARMA Market Cap
KOREA PHARMA has a market cap or net worth of 155.97 billion as of May 13, 2025. Its market cap has decreased by -29.03% in one year.
Market Cap
155.97B
Enterprise Value
141.17B
Revenue
81.28B
Ranking
n/a
PE Ratio
41.09
Stock Price
14,110.00
Market Cap Chart
Since August 10, 2020, KOREA PHARMA's market cap has decreased from 183.78B to 155.97B, a decrease of -15.13%. That is a compound annual growth rate of -3.39%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 12, 2025 | 154.55B | -7.45% |
Dec 30, 2024 | 166.98B | -35.26% |
Dec 28, 2023 | 257.94B | 10.51% |
Dec 29, 2022 | 233.40B | -55.92% |
Dec 30, 2021 | 529.52B | 118.69% |
Dec 30, 2020 | 242.13B | 31.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 361.77T |
SK hynix | 130.99T |
LG Energy Solution | 74.41T |
Samsung Biologics | 74.02T |
Hyundai Motor Company | 41.61T |
Hanwha Aerospace | 39.92T |
HD Hyundai Heavy Industries | 36.66T |
Kia Corporation | 35.16T |